These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 33039102)
1. Possible apixaban-induced agranulocytosis: A life-threatening adverse drug reaction causing by a widely prescribed drug. Chen P; Zamy M; Nili-Asgari R; Cymbalista F; Dhôte R; Abad S Therapie; 2021; 76(5):499-500. PubMed ID: 33039102 [No Abstract] [Full Text] [Related]
2. Possible role of free radical formation in drug-induced agranulocytosis. Mason RP; Fischer V Drug Saf; 1992; 7 Suppl 1():45-50. PubMed ID: 1503677 [TBL] [Abstract][Full Text] [Related]
3. Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports. Fernandez S; Lenoir C; Samer C; Rollason V Pharmacol Res Perspect; 2020 Oct; 8(5):e00647. PubMed ID: 32881416 [TBL] [Abstract][Full Text] [Related]
4. Idiosyncratic drug-induced agranulocytosis: the paradigm of deferiprone. Pontikoglou C; Papadaki HA Hemoglobin; 2010 Jun; 34(3):291-304. PubMed ID: 20524819 [TBL] [Abstract][Full Text] [Related]
5. Drug-associated agranulocytosis: 20 years of reporting in The Netherlands (1974-1994). van der Klauw MM; Wilson JH; Stricker BH Am J Hematol; 1998 Mar; 57(3):206-11. PubMed ID: 9495370 [TBL] [Abstract][Full Text] [Related]
6. Nonchemotherapy drug-induced neutropenia and agranulocytosis: could medications be the culprit? Pick AM; Nystrom KK J Pharm Pract; 2014 Oct; 27(5):447-52. PubMed ID: 25124379 [TBL] [Abstract][Full Text] [Related]
7. Necrotizing stomatitis: a possible periodontal manifestation of deferiprone-induced agranulocytosis. Tewari S; Tewari S; Sharma RK; Abrol P; Sen R Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Oct; 108(4):e13-9. PubMed ID: 19778731 [TBL] [Abstract][Full Text] [Related]
8. Pediatric drug safety signal detection of non-chemotherapy drug-induced neutropenia and agranulocytosis using electronic healthcare records. Wei R; Jia LL; Yu YC; Nie XL; Song ZY; Fan DF; Xie YF; Peng XX; Zhao ZG; Wang XL Expert Opin Drug Saf; 2019 May; 18(5):435-441. PubMed ID: 31002530 [No Abstract] [Full Text] [Related]
9. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis. Andrès E; Federici L; Weitten T; Vogel T; Alt M Expert Opin Drug Saf; 2008 Jul; 7(4):481-9. PubMed ID: 18613811 [TBL] [Abstract][Full Text] [Related]
10. [Drug induced neutropenia and agranulocytosis]. Sacchetti C Haematologica; 1972; 57(7):293-306. PubMed ID: 4628581 [No Abstract] [Full Text] [Related]
15. The impact of previous or concomitant IFN therapy on deferiprone-induced agranulocytosis and neutropenia: a retrospective study. Ricchi P; Ammirabile M; Costantini S; Cinque P; Lanza AG; Spasiano A; Di Matola T; Di Costanzo G; Pagano L; Prossomariti L Expert Opin Drug Saf; 2010 Nov; 9(6):875-81. PubMed ID: 20945995 [TBL] [Abstract][Full Text] [Related]
16. Deferiprone-induced agranulocytosis: 20 years of clinical observations. Tricta F; Uetrecht J; Galanello R; Connelly J; Rozova A; Spino M; Palmblad J Am J Hematol; 2016 Oct; 91(10):1026-31. PubMed ID: 27415835 [TBL] [Abstract][Full Text] [Related]
17. Drug-induced neutropenia in the Stockholm region 1973-75: frequency and causes. Arneborn P; Palmblad J Acta Med Scand; 1978; 204(4):283-6. PubMed ID: 80921 [TBL] [Abstract][Full Text] [Related]